At the news
? NEUTRALIMPACT 2/10 CLUSTER filed Aug 31, 2026 at 16:11 ET
Three Medpace insiders (CEO, CFO, Director) sold a combined $4.91M in open-market sales over a 7-day window. However, this represents only ~0.03% of the company's $16.8B market cap, making it a trivial, routine cluster unlikely to carry informational content. The sales are too small relative to company size to signal a bearish view, and the Director's sale was part of a derivative exercise-and-sell pattern, further reducing significance.
- Total open-market insider sales: $4.91M across 3 insiders (CEO, CFO, Director)
- Sales represent only ~0.03% of MEDP's $16.8B market cap
- CEO August Troendle sold 4,650 shares total (~$2.88M), CFO Kevin Brady sold 3,400 shares (~$2.13M)
- Director Robert Kraft's $2.38M sale was part of a derivative exercise-and-sell pattern (non-cash exercise at $0)
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access